What is amyloidosis?

What does it mean to be triple class refractory?
What is whole genome sequencing? How has whole-genome sequencing been used to identify progressive versus stable myeloma precursor conditions as two distinct entities?
What is the role of supportive care throughout relapsed and refractory myeloma management?
Should someone diagnosed with smoldering multiple myeloma (SMM) see a myeloma specialist?
Is the risk of cardiac toxicity of CAR-T cell therapy?
Are there any tests that can predict what myeloma treatments you will respond to?
What treatment is used for a solitary plasmacytoma?
What vaccinations should myeloma patients be getting to help prevent infections?